Inhaled Antibiotic Cuts Risk of Ventilator-Associated Pneumonia
A short course of an inhaled antibiotic helped prevent the incidence of ventilator-associated pneumonia in the intensive care unit (ICU), a randomized trial in France showed. In critically ill patients intubated for between 3 to 4 days, administration of amikacin (Arikayce) reduced the rate of first ventilator-associated pneumonia compared with an inhaled placebo (15% vs […]